370 related articles for article (PubMed ID: 33126150)
21. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
Huang Y; Yin Y; Zhou W
Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
[TBL] [Abstract][Full Text] [Related]
23. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
24. Clinical analysis of cervical lymph node metastasis patterns and multivariate factors in differentiated thyroid carcinoma.
Liu J; Guo M
Oncol Lett; 2023 Oct; 26(4):431. PubMed ID: 37664651
[TBL] [Abstract][Full Text] [Related]
25. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
26. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
[TBL] [Abstract][Full Text] [Related]
28. Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC.
Huang H; Xu S; Ni S; Liu W; Liu S
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15525-15533. PubMed ID: 37646829
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.
Tao Y; Wang C; Li L; Xing H; Bai Y; Han B; Liu Z; Yang X; Zhu S
Mol Clin Oncol; 2017 Jan; 6(1):49-55. PubMed ID: 28123728
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
Zhang X; Zhang L; Xue S; Wang P; Chen G
Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract][Full Text] [Related]
32. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
33. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
[TBL] [Abstract][Full Text] [Related]
34. Clinical Analysis of Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 3686 Patients.
Song J; Yan T; Qiu W; Fan Y; Yang Z
Cancer Manag Res; 2020; 12():2523-2530. PubMed ID: 32308489
[TBL] [Abstract][Full Text] [Related]
35. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
[TBL] [Abstract][Full Text] [Related]
36. The influence of papillary thyroid microcarcinomas size on the occurrence of lymph node metastases.
Goran M; Markovic I; Buta M; Gavrilovic D; Cvetkovic A; Santrac N; Rakovic M; Milijic NM; Dzodic R
J BUON; 2019; 24(5):2120-2126. PubMed ID: 31786884
[TBL] [Abstract][Full Text] [Related]
37. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Single-Center Retrospective Study.
Cheng F; Chen Y; Zhu L; Zhou B; Xu Y; Chen Y; Wen L; Chen S
Int J Endocrinol; 2019; 2019():8579828. PubMed ID: 30774660
[TBL] [Abstract][Full Text] [Related]
39. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
40. The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.
Lin Y; Cui N; Li F; Wang Y; Wang B
Front Endocrinol (Lausanne); 2024; 15():1330896. PubMed ID: 38745958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
